Radiation Protection Dosimetry Advance Access originally published online on June 2, 2007
Radiation Protection Dosimetry 2007 127(1-4):148-152; doi:10.1093/rpd/ncm266
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Comparisons of 239Pu inhalation doses calculated with ICRP 67 and proposed systemic models
GSF—National Research Center for Environment and Health, Institute of Radiation Protection, Ingolstädter Landstraße 1, D-85764 Neuherberg, Germany
* Corresponding author: wli{at}gsf.de
The International Commission on Radiological Protection (ICRP) has issued an age-specific systemic biokinetic model for plutonium (Pu), which was later modified to give better agreement with measured urinary excretion data. Recently, the current ICRP systemic Pu model was improved by Leggett et al. based on recently developed data. Incorporation of 239Pu in the human body may result in significant internal radiation exposure. In the present work, the retentions in organs and tissues, the equivalent dose and effective dose from 239Pu for workers and members of the public were estimated and compared under the current ICRP and the proposed models. 239Pu contents in liver and in other soft tissue calculated with the proposed model are higher than predicted by the ICRP model, whereas bone content is lower than predicted by the ICRP model. Based on the proposed model, the inhalation equivalent dose coefficient in some organs, e.g. liver and kidneys, is increased, but there is no significant change in the effective inhalation dose coefficients of 239Pu for workers and members of the public.